Literature DB >> 8380533

Rapid development of lymphoma following liver transplantation in a recipient with hepatitis B and primary hemochromatosis.

J P Palazzo1, K Lundquist, D Mitchell, K R Mittal, H W Hann, S Munoz, M J Moritz, J M Jacobs, P Martin.   

Abstract

We report a case of a posttransplant lymphoproliferative disorder (PTLD) which presented in a liver allograft shortly after transplantation. The patient, who had been transplanted because of cirrhosis due to primary hemochromatosis and chronic hepatitis B infection (HBV), developed early recurrent HBV in the graft, and 2 months after transplantation, liver biopsies showed a malignant large-cell lymphoma. The neoplastic cells demonstrated Epstein-Barr virus DNA by in situ hybridization. The patient died 3.5 months posttransplant due to liver failure. At autopsy, the liver showed nodules of malignant lymphoma, massive hepatic necrosis, and iron overload, but no evidence of rejection. This report suggests that the grafted liver can be the site of PTLD in recurrent HBV and hemochromatosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8380533

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  5 in total

Review 1.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

2.  HODGKIN'S DISEASE WITH IDIOPATHIC HEMOCHROMATOSIS.

Authors:  G U Deshpande; A C Anand; Ramji Rai
Journal:  Med J Armed Forces India       Date:  2017-06-26

3.  Chronic iron overload in rats induces oval cells in the liver.

Authors:  P G Smith; G C Yeoh
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

4.  Primary hepatic high-grade non-Hodgkin's lymphoma and chronic hepatitis C infection.

Authors:  M Möhler; F Gutzler; B Kallinowski; T Goeser; W Stremmel
Journal:  Dig Dis Sci       Date:  1997-11       Impact factor: 3.199

5.  Primary Hepatic Lymphoma: A Retrospective, Multicenter Rare Cancer Network Study.

Authors:  Gamze Ugurluer; Robert C Miller; Yexiong Li; Juliette Thariat; Pirus Ghadjar; Ulrike Schick; Mahmut Ozsahin
Journal:  Rare Tumors       Date:  2016-10-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.